QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
NASDAQ:ACET

Adicet Bio - ACET News Today

$9.15
+0.46 (+5.29%)
(As of 01/31/2023 05:18 PM ET)
Add
Compare
Today's Range
$8.69
$9.27
50-Day Range
$7.63
$20.19
52-Week Range
$7.42
$21.87
Volume
355,553 shs
Average Volume
556,693 shs
Market Capitalization
$392.08 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$27.71
Get Adicet Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter.



ACET Media Mentions By Week

ACET Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACET
News Sentiment

0.44

0.72

Average
Medical
News Sentiment

ACET News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACET Articles
This Week

4

1

ACET Articles
Average Week

SourceHeadline
forbes.com logoAdicet Bio
forbes.com - January 26 at 7:18 AM
finance.yahoo.com logoAre Medical Stocks Lagging Adicet Bio (ACET) This Year?
finance.yahoo.com - January 25 at 3:29 PM
reuters.com logoACET.C - | Stock Price & Latest News | Reuters
reuters.com - January 25 at 10:13 AM
MarketBeat logoShort Interest in Adicet Bio, Inc. (NASDAQ:ACET) Drops By 6.8%
americanbankingnews.com - January 24 at 7:57 AM
finance.yahoo.com logoDown -53.98% in 4 Weeks, Here's Why You Should You Buy the Dip in Adicet Bio, Inc. (ACET)
finance.yahoo.com - December 30 at 1:09 PM
finance.yahoo.com logoShareholders in Adicet Bio (NASDAQ:ACET) have lost 49%, as stock drops 22% this past week
finance.yahoo.com - December 20 at 9:49 AM
msn.com logoAdicet Bio, Inc. (ACET) Loses 47% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
msn.com - December 14 at 2:10 PM
msn.com logoPeering Into Adicet Bio's Recent Short Interest
msn.com - December 13 at 6:08 PM
finance.yahoo.com logoAdicet Bio Shares Fall After Underwhelming Data From Non-Hodgkin's Lymphoma Study
finance.yahoo.com - December 12 at 9:07 PM
seekingalpha.com logoAdicet Bio plunges 38% after updating Phase 1 data for blood cancer therapy
seekingalpha.com - December 12 at 3:57 PM
bloomberg.com logoAdicet Bio Plummets After Cancer Drug Trial Disappoints Investors
bloomberg.com - December 12 at 3:57 PM
finance.yahoo.com logoAdicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
finance.yahoo.com - December 10 at 4:21 PM
nasdaq.com logoWhat Makes Adicet Bio, Inc. (ACET) a Good Fit for 'Trend Investing'
nasdaq.com - December 7 at 5:44 PM
finance.yahoo.com logoIs Adicet Bio (ACET) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - December 7 at 5:44 PM
finance.yahoo.com logoAdicet Bio to Host Investor Webcast to Discuss Updated Clinical Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
finance.yahoo.com - December 2 at 8:54 AM
finance.yahoo.com logoAdicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit
finance.yahoo.com - November 30 at 5:14 PM
finance.yahoo.com logoWall Street Analysts Think Adicet Bio, Inc. (ACET) Could Surge 72%: Read This Before Placing a Bet
finance.yahoo.com - November 29 at 1:12 PM
finance.yahoo.com logoAdicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer
finance.yahoo.com - November 29 at 8:11 AM
msn.com logoIs Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?
msn.com - November 11 at 12:57 PM
msn.com logoWall Street Analysts See a 39% Upside in Adicet Bio, Inc. (ACET): Can the Stock Really Move This High?
msn.com - November 11 at 12:57 PM
finance.yahoo.com logoAdicet Bio Third Quarter 2022 Earnings: US$0.53 loss per share (vs US$0.44 loss in 3Q 2021)
finance.yahoo.com - November 11 at 7:56 AM
msn.com logoAdicet Bio, Inc. (ACET) Reports Q3 Loss, Misses Revenue Estimates
msn.com - November 8 at 9:46 PM
finance.yahoo.com logoAdicet Reports Third Quarter 2022 Financial Results and Provides Business Updates
finance.yahoo.com - November 8 at 4:30 PM
finance.yahoo.com logoAdicet Bio Showcases Preclinical Data for Four New Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
finance.yahoo.com - November 7 at 11:49 AM
markets.businessinsider.com logoBTIG Keeps Their Buy Rating on Adicet Bio (ACET)
markets.businessinsider.com - November 4 at 6:01 AM
finance.yahoo.com logoAdicet Bio Reports ASH Abstract Data from Ongoing ADI-001 Phase 1 Trial in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
finance.yahoo.com - November 3 at 12:10 PM
finance.yahoo.com logoAdicet Bio to Present at the 2022 Jefferies London Healthcare Conference
finance.yahoo.com - November 1 at 7:10 AM
finance.yahoo.com logoCalculating The Intrinsic Value Of Adicet Bio, Inc. (NASDAQ:ACET)
finance.yahoo.com - October 23 at 12:30 PM
nasdaq.com logoA Look At The Intrinsic Value Of Adicet Bio, Inc. (NASDAQ:ACET)
nasdaq.com - October 14 at 6:28 PM
finance.yahoo.com logoAdicet Bio to Present Preclinical Data from Allogeneic Gamma Delta T Cell Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
finance.yahoo.com - October 5 at 1:29 PM
bizjournals.com logoRedwood City biotech adds space exactly where it needed it: 'We just didn't have enough room'
bizjournals.com - September 13 at 12:59 PM
MarketBeat logoAdicet Bio, Inc. (NASDAQ:ACET) Receives Average Recommendation of "Moderate Buy" from Analysts
americanbankingnews.com - September 12 at 6:27 AM
nasdaq.com logoDespite shrinking by US$93m in the past week, Adicet Bio (NASDAQ:ACET) shareholders are still up 99% over 1 year
nasdaq.com - August 16 at 8:42 PM
finance.yahoo.com logoThe Consensus EPS Estimates For Adicet Bio, Inc. (NASDAQ:ACET) Just Fell Dramatically
finance.yahoo.com - August 16 at 10:41 AM
seekingalpha.com logoAdicet Bio, (ACET) Investor Presentation - Slideshow
seekingalpha.com - August 14 at 9:59 PM
nasdaq.com logoAdicet Bio Posts Wider Loss In Q2
nasdaq.com - August 10 at 1:06 PM
finance.yahoo.com logoAdicet Bio, Inc. (ACET) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 10 at 1:06 PM
finance.yahoo.com logoAdicet Bio, Inc. (ACET) Is a Great Choice for "Trend" Investors, Here's Why
finance.yahoo.com - July 18 at 11:54 AM
seekingalpha.com logoAdicet Bio updates Phase 1 data for CAR-T candidate in blood cancer
seekingalpha.com - June 6 at 11:47 AM
finance.yahoo.com logoAdicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - June 6 at 11:47 AM
seekingalpha.com logoAdicet Bio gains after updating early-stage data for CAR-T therapy in blood cancer
seekingalpha.com - May 27 at 11:29 AM
finance.yahoo.com logoAdicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory Non-Hodgkin’s Lymphoma (NHL)
finance.yahoo.com - May 26 at 8:20 PM
finance.yahoo.com logoAdicet Bio to Present at Upcoming Investor Conferences
finance.yahoo.com - May 18 at 5:09 PM
finance.yahoo.com logoResults: Adicet Bio, Inc. Confounded Analyst Expectations With A Surprise Profit
finance.yahoo.com - May 15 at 9:42 AM
finance.yahoo.com logoAdicet Reports First Quarter 2022 Financial Results and Provides Business Updates
finance.yahoo.com - May 13 at 2:06 AM
finance.yahoo.com logoFurther weakness as Adicet Bio (NASDAQ:ACET) drops 31% this week, taking one-year losses to 17%
finance.yahoo.com - May 12 at 3:26 PM
finance.yahoo.com logoAdicet Presents Preclinical Data at the ISCT Annual Meeting Highlighting Potential Advantages of the Non-Gene-Edited Approach for its Investigational Allogeneic Gamma Delta CAR T Cell Therapy Targeting CD20 for B Cell Malignancies
finance.yahoo.com - May 5 at 8:53 AM
finance.yahoo.com logoAdicet Bio Announces Oral Presentation of Updated ADI-001 Phase 1 Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
finance.yahoo.com - April 27 at 10:50 AM
seekingalpha.com logoAdicet Bio stock soars 13% on FDA fast track status for ADI-001 to treat blood cancer
seekingalpha.com - April 19 at 9:04 AM
nasdaq.com logoAdicet Bio's Lead Candidate ADI-001 Gets FDA Fast Track Designation - Quick Facts
nasdaq.com - April 19 at 9:04 AM
Get Adicet Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ACET) was last updated on 1/31/2023 by MarketBeat.com Staff